Nocturia is a fairly common condition that is typically associated with aging and benign prostatic hyperplasia (BPH) or simply, an enlarged prostate. Nocturia is defined by the International Continence Society (ICS) as “the complaint that the individual has to wake at night one or more times for voiding.” Diagnosing nocturia requires knowing the patient’s nocturnal urine volume (NUV). NUV is the total volume of urine passed between the time and individual goes to bed and the time of waking up with the intent of rising.
Benign prostatic hyperplasia or BPH is the enlargement of the prostate gland. The prostate gland surrounds the urethra, the tube that carries urine from the bladder out of the body. As the prostate gets bigger, it may squeeze or partly block the urethra. This often causes problems with urinating. BPH occurs in almost all men when they age. BPH is not caner. An enlarged prostate can be a nuisance, but is usually not a serious problem.
If you have been diagnosed with BPH, or an enlarged prostate gland and are bothered by nocturia, you may qualify for the EQUINOC study. The EQUINOC study is a clinical research study being conducted to evaluate an investigational drug to reduce the number of times you wake up to urinate at night (nocturia).
In order to qualify you must:
Qualified participants will receive all study medication and study-related care from a dedicated team of medical staff at no cost. Health insurance is not required to participate. Compensation for time and travel is available.
If you would like more information or to see if you qualify, sign up for this study on our PARTICIPANT SIGN UP FORM and a member of our team will contact you.